BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17149650)

  • 61. The 2003-2008 Australian Health Care Agreements--an industry perspective.
    Cormack M
    Aust Health Rev; 2002; 25(6):27-32. PubMed ID: 12536859
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Funding Victoria's public hospitals: the casemix policy of 2000-2001.
    McNair P; Duckett S
    Aust Health Rev; 2002; 25(1):72-98. PubMed ID: 11974961
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Private health insurance: the problem child faces adulthood.
    Cormack M
    Aust Health Rev; 2002; 25(2):38-51. PubMed ID: 12046153
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Japanese government policy on hospital pharmaceutical profit levels.
    Oliver AJ; Ikegami N; Ikeda S
    J Health Serv Res Policy; 1999 Jan; 4(1):27-32. PubMed ID: 10345563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Equity, governance and financing after health care reform: lessons from Mexico.
    Arredondo A; Orozco E
    Int J Health Plann Manage; 2008; 23(1):37-49. PubMed ID: 18000949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines.
    Scavone C; Carnovale C; Ruggiero R; Radice S; Scatigna M; Racagni G; Mugelli A; Rossi F; Clementi E; Capuano A
    Clin Ther; 2018 Nov; 40(11):1931-1940. PubMed ID: 30458933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Towards an improved and more cost effective health system for Australia.
    Harper RW
    Med J Aust; 1998 Mar; 168(6):286-7, 290-1. PubMed ID: 9549537
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Private finance initiative. At the top of a slippery slope?
    Akid M
    Nurs Times; 2001 Oct 25-31; 97(43):14. PubMed ID: 11966072
    [No Abstract]   [Full Text] [Related]  

  • 69. Evaluation of barriers to sustainable medication access in Honduras.
    Narayanan N; Stoffella SS; Roy-Burman A; Lynch M; Ifland L; Brock T
    Am J Health Syst Pharm; 2016 May; 73(10):618-26. PubMed ID: 27147213
    [No Abstract]   [Full Text] [Related]  

  • 70. A review of the medication pathway in rural Queensland, Australia.
    Tan AC; Emmerton L; Hattingh HL
    Int J Pharm Pract; 2012 Oct; 20(5):324-39. PubMed ID: 22953772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Competition policy for health care provision in France.
    Choné P
    Health Policy; 2017 Feb; 121(2):111-118. PubMed ID: 27993434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Casemix based funding for private hospitals or there are still a number of options so can we please slow down.
    Herring MM
    Aust Health Rev; 1991; 14(3):255-63. PubMed ID: 10117334
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Health care markets in Australia: ownership of the private hospital sector.
    White K; Collyer F
    Int J Health Serv; 1998; 28(3):487-510. PubMed ID: 9711477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Managed entry agreements for pharmaceuticals in Australia.
    Vitry A; Roughead E
    Health Policy; 2014 Sep; 117(3):345-52. PubMed ID: 24957419
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Free choice, equity, and care: the moral foundations of health care.
    Ho-mun C
    J Med Philos; 1999 Dec; 24(6):624-37. PubMed ID: 10709773
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inequity in publicly funded physician care: what is the role of private prescription drug insurance?
    Allin S; Hurley J
    Health Econ; 2009 Oct; 18(10):1218-32. PubMed ID: 19097042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The free delivery of drugs during hospital consultations].
    Haus R; Moutel G; Montuclard L; François I; Frebault M; Rozenbaum L; Bertrandon R; Hervé C
    Presse Med; 2003 Sep; 32(28):1303-9. PubMed ID: 14506437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hospital pharmacy in Australia.
    Miller BR
    Am J Hosp Pharm; 1978 Jun; 35(6):673-7. PubMed ID: 665680
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.